Press Releases Filter Options Archive DateYear20262025202420232022202120202019201820172016201520142013201220112010200920082007MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember View 12 View 12View 24View 48 Categories CorporateFinancialPrescription MedicinesResearch and PipelineSocial ResponsibilityVaccines Keywords All Keywords Covid-19FinanceInvestmentsLeadershipMedicinesPartnershipsResearchResponsibilityVaccines June 2022 06.28.2022 Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and LupusFinancialInvestments 06.24.2022 Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with AnalystsFinancialFinance 06.23.2022 Valneva and Pfizer Announce Closing of Equity InvestmentFinancialInvestmentsVaccines 06.23.2022 Pfizer Declares Third-Quarter 2022 DividendFinancialFinance 06.09.2022 Pfizer Completes Acquisition of ReViralFinancialInvestments 06.06.2022 Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.FinancialCovid-19InvestmentsVaccines March 2022 03.11.2022 Pfizer Completes Acquisition of Arena PharmaceuticalsFinancialFinanceInvestments Page 4 Page 5 Page 6 Page 7 Current page 8
